BRK-B vs EQS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Equus Total Return, Inc. (EQS) exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9. The company is suffering from profound operational inefficiency with an operating margin of -118.32% and a negative ROE of -61.48%, indicating significant destruction of shareholder equity. With a current ratio of 0.84, the company faces immediate liquidity risks, while a technical trend score of 0/100 and recent sharp price declines confirm strong bearish momentum. The lack of revenue growth and absence of earnings make the current valuation unsustainable.
Compare Another Pair
Related Comparisons
BRK-B vs EQS: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Equus Total Return, Inc. (EQS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.